Amazon begins selling Novo Nordisk's Wegovy pill in U.S.

Amazon has started selling Novo Nordisk's new oral Wegovy weight‑loss pill in the United States, where Novo Nordisk began rolling it out on Jan. 5; Amazon says it will also add the pill to prescription kiosks in select One Medical clinics in the coming weeks.

Amazon has begun selling Novo Nordisk's new oral Wegovy weight‑loss pill in the United States, with the rollout starting on Jan. 5. Novo Nordisk is offering a starting monthly dose priced at $149, and some patients with insurance can pay as little as $25 per month. The pill arrives amid a fast-moving market for weight‑loss and diabetes medicines led by Novo Nordisk and Eli Lilly. Amazon launched Amazon Pharmacy in 2020 and has been expanding its healthcare services, emphasizing speedy delivery and price transparency. Key facts: - Novo Nordisk began U.S. rollout of an oral version of Wegovy on Jan. 5, with a starting dose priced at $149 per month. - Patients with insurance coverage can obtain the pill for about $25 per month, according to the article. - Amazon said it will sell the pill on Amazon and will add it to prescription vending kiosks in select One Medical clinics in the coming weeks. - Amazon Pharmacy, launched in 2020, currently offers same‑day prescription delivery to nearly half of U.S. consumers, per the article. - The oral Wegovy pill is now available at more than 70,000 U.S. pharmacies and at Costco Wholesale. - The article notes that Novo Nordisk reached market ahead of Eli Lilly, whose rival oral weight‑loss pill is expected to seek FDA approval later this year. Summary: Amazon's listing expands retail and clinic-based access to Novo Nordisk's new oral Wegovy pill in the U.S. Amazon will add the drug to prescription kiosks in select One Medical clinics in the coming weeks, while Eli Lilly's competing oral therapy is slated for FDA review later this year.